SCHEMBL17127353

SCHEMBL17127353

CCOCCSC(C(=O)c1ccc(Oc2ccc3cc(OC)c(OC)cc3c2)cc1OC)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 2/20 0.40
▸ APP P05067 2/20 0.35
▸ PDE4A P27815 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ PDE4C Q08493 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPC1 O15118 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ AHR P35869 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ ABCG2 Q9UNQ0 2/20 0.32
▸ AKR1C3 P42330 3/20 0.32
▸ AKR1C2 P52895 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17127350 0.95 HIF1A (0.39) HIF1AAPPPDE4APDE4BPDE4C
SCHEMBL17126864 0.89 SCN9A (0.33) TP53LMNASMN1; SMN2NPC1KDM4E
SCHEMBL17126862 0.82 AKR1C3 (0.39) LMNAHTTSMN1; SMN2KDM4EALDH1A1
SCHEMBL17127328 0.81 CDC25B (0.37) APPLMNAKDM4EALDH1A1MEN1
SCHEMBL17126861 0.80 CNR1 (0.39) NPC1RAB9A
SCHEMBL17126856 0.80 SMN1; SMN2 (0.33) LMNASMN1; SMN2MEN1KMT2A
SCHEMBL17126857 0.79 APP (0.36) HIF1AAPPLMNAHTTSMN1; SMN2
SCHEMBL17127331 0.78 CNR2 (0.42) —
SCHEMBL17126975 0.78 TTR (0.39) HIF1AAPPLMNAHTTSMN1; SMN2
SCHEMBL17127022 0.78 PTGS2 (0.38) LMNASMN1; SMN2NPC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS HIF1A 3192/4885APP 1536/4885PDE4A 4160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback